» Authors » Miriam R Schafer

Miriam R Schafer

Explore the profile of Miriam R Schafer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 1138
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hartmann S, Dwyer D, Cavve B, Byrne E, Scott I, Gao C, et al.
World Psychiatry . 2024 Sep; 23(3):400-410. PMID: 39279417
The concept of ultra-high risk for psychosis (UHR) has been at the forefront of psychiatric research for several decades, with the ultimate goal of preventing the onset of psychotic disorder...
2.
Allott K, Schmidt S, Yuen H, Wood S, Nelson B, Markulev C, et al.
Schizophr Bull Open . 2024 Aug; 3(1):sgac008. PMID: 39144786
Understanding longitudinal cognitive performance in individuals at ultra-high risk for psychosis (UHR) is important for informing theoretical models and treatment. A vital step in this endeavor is to determine whether...
3.
Nelson B, Yuen H, Amminger G, Berger G, Chen E, de Haan L, et al.
Schizophr Bull Open . 2024 Aug; 3(1):sgaa006. PMID: 39144772
This study examined whether distress in relation to attenuated psychotic symptoms (DAPS) is associated with clinical outcomes in an ultra-high risk (UHR) for psychosis sample. We also investigated whether DAPS...
4.
Byrne J, Healy C, Focking M, Susai S, Mongan D, Wynne K, et al.
Schizophr Bull . 2024 Jan; 50(3):579-588. PMID: 38243809
Psychosis risk prediction is one of the leading challenges in psychiatry. Previous investigations have suggested that plasma proteomic data may be useful in accurately predicting transition to psychosis in individuals...
5.
Susai S, Healy C, Mongan D, Heurich M, Byrne J, Cannon M, et al.
Transl Psychiatry . 2022 Oct; 12(1):454. PMID: 36307392
Preliminary evidence indicates beneficial effects of omega-3 polyunsaturated fatty acids (PUFAs) in early psychosis. The present study investigates the molecular mechanism of omega-3 PUFA-associated therapeutic effects in clinical high-risk (CHR)...
6.
Cheng N, McLaverty A, Nelson B, Markulev C, Schafer M, Berger M, et al.
BJPsych Open . 2022 Sep; 8(5):e165. PMID: 36073014
Background: Cognitive impairments are well-established features of psychotic disorders and are present when individuals are at ultra-high risk for psychosis. However, few interventions target cognitive functioning in this population. Aims:...
7.
Susai S, Mongan D, Healy C, Cannon M, Cagney G, Wynne K, et al.
Brain Behav Immun . 2022 Mar; 103:50-60. PMID: 35341915
Background: Functional outcomes are important measures in the overall clinical course of psychosis and individuals at clinical high-risk (CHR), however, prediction of functional outcome remains difficult based on clinical information...
8.
Susai S, Mongan D, Healy C, Cannon M, Nelson B, Markulev C, et al.
Brain Behav Immun . 2021 Oct; 99:147-156. PMID: 34624483
There is increasing evidence that dysregulation of polyunsaturated fatty acids (FAs) mediated membrane function plays a role in the pathophysiology of schizophrenia. Even though preclinical findings have supported the anti-inflammatory...
9.
Shetty J, Nicholas C, Nelson B, McGorry P, Lavoie S, Markulev C, et al.
Early Interv Psychiatry . 2021 Feb; 15(6):1793-1798. PMID: 33538110
Aim: Investigating biological processes in at-risk individuals may help elucidate the aetiological mechanisms underlying psychosis development, refine prediction models and improve intervention strategies. This study examined the associations between sleep...
10.
ODonoghue B, Geros H, Sizer H, Addington J, Amminger G, Beaden C, et al.
Soc Psychiatry Psychiatr Epidemiol . 2021 Jan; 56(6):943-952. PMID: 33399885
Purpose: Migrant status is one of the most replicated and robust risk factors for developing a psychotic disorder. This study aimed to determine whether migrant status in people identified as...